BGMSP
Price
$5.75
Change
-$0.13 (-2.21%)
Updated
Oct 1, 11:53 AM (EDT)
Capitalization
N/A
SRPT
Price
$23.25
Change
+$0.61 (+2.69%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
2.43B
22 days until earnings call
Interact to see
Advertisement

BGMSP vs SRPT

Header iconBGMSP vs SRPT Comparison
Open Charts BGMSP vs SRPTBanner chart's image
Bio Green Med Solution
Price$5.75
Change-$0.13 (-2.21%)
VolumeN/A
CapitalizationN/A
Sarepta Therapeutics
Price$23.25
Change+$0.61 (+2.69%)
Volume$70.54K
Capitalization2.43B
BGMSP vs SRPT Comparison Chart in %
BGMSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGMSP vs. SRPT commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMSP is a Hold and SRPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (BGMSP: $5.88 vs. SRPT: $23.26)
Brand notoriety: BGMSP: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGMSP: 303% vs. SRPT: 74%
Market capitalization -- BGMSP: $0 vs. SRPT: $2.43B
BGMSP [@Biotechnology] is valued at $0. SRPT’s [@Biotechnology] market capitalization is $2.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGMSP’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BGMSP’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, BGMSP is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGMSP’s TA Score shows that 5 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • BGMSP’s TA Score: 5 bullish, 5 bearish.
  • SRPT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than BGMSP.

Price Growth

BGMSP (@Biotechnology) experienced а -0.34% price change this week, while SRPT (@Biotechnology) price change was +23.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Reported Earning Dates

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGMSP YTD gains are higher at: -19.342 vs. SRPT (-80.870).
BGMSPSRPTBGMSP / SRPT
CapitalizationN/A2.44B-
EBITDAN/A36.1M-
Gain YTD-19.342-80.87024%
P/E RatioN/A27.21-
RevenueN/A2.48B-
Total CashN/A800M-
Total DebtN/A1.35B-
FUNDAMENTALS RATINGS
BGMSP vs SRPT: Fundamental Ratings
BGMSP
SRPT
OUTLOOK RATING
1..100
5020
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
4363
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BGMSP's Valuation (1) in the Biotechnology industry is significantly better than the same rating for SRPT (72). This means that BGMSP’s stock grew significantly faster than SRPT’s over the last 12 months.

BGMSP's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as SRPT (100). This means that BGMSP’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (93) in the Biotechnology industry is in the same range as BGMSP (100). This means that SRPT’s stock grew similarly to BGMSP’s over the last 12 months.

BGMSP's Price Growth Rating (43) in the Biotechnology industry is in the same range as SRPT (63). This means that BGMSP’s stock grew similarly to SRPT’s over the last 12 months.

BGMSP's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that BGMSP’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BGMSPSRPT
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 15 days ago
90%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BGMSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEKIX22.91N/A
N/A
DWS Emerging Markets Equity Inst
IPLIX30.16N/A
N/A
Voya Index Plus LargeCap Port I
PRWAX84.99N/A
N/A
T. Rowe Price All-Cap Opportunities Fund
ARGFX80.95N/A
N/A
Ariel Fund Investor
MACEX16.05N/A
N/A
ClearBridge Emerging Markets A

BGMSP and

Correlation & Price change

A.I.dvisor tells us that BGMSP and VALN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGMSP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGMSP
1D Price
Change %
BGMSP100%
N/A
VALN - BGMSP
24%
Poorly correlated
-3.25%
SRPT - BGMSP
23%
Poorly correlated
+2.74%
AURA - BGMSP
21%
Poorly correlated
-2.15%
KZIA - BGMSP
21%
Poorly correlated
+3.35%
TECH - BGMSP
21%
Poorly correlated
-1.64%
More